LMG Life Sciences Americas 2024: research cycle open

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Americas 2024: research cycle open

Life Sciences website image 2024.png

The Americas research cycle has commenced. Do not miss this opportunity to nominate your work!

LMG Life Sciences is excited to announced the launch of the 2024 Americas research. We continue to recognize the top firms, lawyers, and legal work serving the Life Sciences industry from across the United States, Canada, and select jurisdictions within Latin America.

The deadline for submissions is 31 May 2024.

You can find detailed information about the rankings and awards by reviewing the methodology or reading the FAQs.

The full list of categories for the rankings and awards can be found on the LMG Life Sciences website.

Important Dates:

Submissions Open

Submissions Close

Shortlist Published

Gala Ceremony

Rankings Published

11 April 2024

31 May 2024

July 2024


September 2024

September 2024


All research submissions must be entered through our dedicated submissions platform. Submissions made in any other format or emailed to us will not be accepted.

For any questions about the awards and/or the rankings research, please contact Research Editor, John Harrison and Research Analyst, Jose Martinez.

For queries about business development and commercial opportunities, please contact George Reeves.

Please note that LMG Life Sciences is a sister publication to and supported by Managing IP but run independently to the IPSTARS research.

more from across site and SHARED ros bottom lb

More from across our site

Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Firms with established sports relationships and specialised expertise are well positioned to capture the market’s expanded pool of IP work
Gunjan Paharia discusses developing RIA, an AI platform built to draw on decades of institutional knowledge, support junior lawyers, and reshape how legal teams work
A strong Canadian business helped lift profits, but the IP service group's latest results underline the pressure facing its operations in Australia, New Zealand and parts of Asia
Wins in court have been key to the six-year-old firm’s growth, as one of its founders explains
The firm’s co-CEO discusses patent litigation, collaboration with overseas colleagues and the next generation of leaders
Two recent decisions demonstrate the courts’ creativity in cutting-edge IP disputes that tested their jurisdictional powers
Aditi Verma Thakur, managing partner at Aishani Partners, discusses 5 am wake-ups, working with high-performing professionals and staying calm under pressure
After more than three decades at Wilson Sonsini, Ian Edvalson explains why he moved to expand his life sciences transactional practice
Gift this article